A Phase 4, Open-Label, Single-Arm Study Assessing the Efficacy and Safety of Ivabradine in African American Patients with Heart Failure and Reduced Ejection Fraction

INTRODUCTION: There are limited data on ivabradine therapy in black patients and none in African Americans. We performed an open-label, prospective study at two centers in the United States. African American patients with heart failure (HF) (N = 30), left ventricular ejection fraction ≤ 35%, and in...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanfear, David E., Neaton, Kelsey R., Lu, Chen, Liu, Yimeng, Dent-Acosta, Ricardo E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584707/
https://www.ncbi.nlm.nih.gov/pubmed/32808163
http://dx.doi.org/10.1007/s40119-020-00196-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584707/
https://www.ncbi.nlm.nih.gov/pubmed/32808163
http://dx.doi.org/10.1007/s40119-020-00196-1

Ejemplares similares